Zanamivir
Back to searchMolecule Structure
Scientific Name
Zanamivir
Description of the Drug
Zanamivir is a neuraminidase inhibitor used to treat influenza A and B.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00558
http://www.drugbank.ca/drugs/DB00558
Brand Name(s)
Relenza
Company Owner(s)
Glaxosmithkline
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Neuraminidase | SINGLE PROTEIN | INHIBITOR | CHEMBL2051 |
Neuraminidase | SINGLE PROTEIN | INHIBITOR | CHEMBL3377 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL9501 | |
PharmGKB | PA164740891 | |
Human Metabolome Database | HMDB0014698 | |
DrugBank | DB00558 | |
PubChem: Thomson Pharma | 14851079 | 14801980 |
PubChem | 60855 | |
Nikkaji | J680.760G | |
PDBe | ZMR | |
BindingDB | 50330326 | 4934 |
EPA CompTox Dashboard | DTXSID0023749 | |
DrugCentral | 2859 | |
Brenda | 2693 | 224532 |
ChemicalBook | CB0292498 | |
rxnorm | ZANAMIVIR | RELENZA |
PubChem: Drugs of the Future | 12014758 | |
KEGG Ligand | C08095 | |
ChEBI | 50663 | |
ZINC | ZINC000003918138 |